Diandra Jennifer Clarissa, Lo Zhiwen Joseph, Ang Wei-Wen, Feng Jue Fei, Narayanan Sriram, Tan Glenn Wei Leong, Chandrasekar Sadhana
Department of General Surgery, Vascular Surgery Service, Tan Tock Seng Hospital, Singapore.
Department of General Surgery, Vascular Surgery Service, Tan Tock Seng Hospital, Singapore.
Ann Vasc Surg. 2018 Jan;46:331-336. doi: 10.1016/j.avsg.2017.07.021. Epub 2017 Jul 23.
To analyze the outcomes of arteriovenous fistulae (AVFs) creation in octogenarians.
A retrospective study of 47 AVFs created in patients aged 80 years and above from 2008 to 2014. Patient and AVF characteristics and outcomes were evaluated. Predictors of patency were analyzed with multivariate analysis and Kaplan-Meier patency, and survival analysis was performed.
Forty-seven of 1,259 AVFs created were for octogenarians (4%). Mean age was 83 years old (range: 80-91 years), with 27 male (57%) and 35 with tunneled dialysis catheters in situ (75%). There were a total of 15 (32%) radiocephalic AVFs, 30 (64%) brachial-cephalic AVFs, and 2 (4%) brachial-basilic transposition AVFs. At 12 months, assisted primary patency rate was 28% (13 patients) while primary failure rate was 72% (34 patients). Subset analysis showed brachial-cephalic AVFs to have the highest assisted primary patency rate at 33%. Within 24 months, tunneled dialysis catheter-related sepsis rate was 31% (11 patients). Multivariate analysis did not reveal any factor to be statistically significant in predicting AVF patency. Kaplan-Meier survival curve showed a 50% survival rate at 63 months after AVF creation.
In view of high AVF primary failure rate and relatively low tunneled dialysis catheter bacteremia rate, long-term tunneled dialysis catheters as the main form of hemodialysis renal access may be a viable option. However, with 50% of end-stage renal failure patients surviving up to 63 months after AVF creation, the risks and benefits of long-term tunneled dialysis catheters must be balanced against those of AVF creation.
分析80岁及以上老人动静脉内瘘(AVF)造瘘的结果。
对2008年至2014年期间为80岁及以上患者创建的47例AVF进行回顾性研究。评估患者及AVF的特征和结果。采用多因素分析、Kaplan-Meier通畅率分析对通畅的预测因素进行分析,并进行生存分析。
在创建的1259例AVF中,有47例是为80岁及以上老人创建的(4%)。平均年龄为83岁(范围:80 - 91岁),其中男性27例(57%),35例(75%)原位留置带隧道涤纶套透析导管。共有15例(32%)为桡动脉-头静脉内瘘,30例(64%)为肱动脉-头静脉内瘘,2例(4%)为肱动脉-尺静脉转位内瘘。12个月时,辅助一期通畅率为28%(13例患者),一期失败率为72%(34例患者)。亚组分析显示,肱动脉-头静脉内瘘的辅助一期通畅率最高,为33%。24个月内,带隧道涤纶套透析导管相关败血症发生率为31%(11例患者)。多因素分析未发现任何因素在预测AVF通畅方面具有统计学意义。Kaplan-Meier生存曲线显示,AVF创建后63个月生存率为50%。
鉴于AVF一期失败率高且带隧道涤纶套透析导管菌血症发生率相对较低,长期带隧道涤纶套透析导管作为血液透析肾通路的主要形式可能是一个可行的选择。然而,由于50%的终末期肾衰竭患者在AVF创建后存活长达63个月,必须权衡长期带隧道涤纶套透析导管与AVF创建的风险和益处。